# An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended

> **NCT05808205** · — · UNKNOWN · sponsor: **Rose Pharma SA** · enrollment: 350 (estimated)

## Conditions studied

- Esthetics

## Interventions

- **DEVICE:** • ALIAXIN EV: Essential Volume • ALIAXIN FL: Lips • ALIAXIN SR: Shape & Restore • ALIAXIN GP: Global Performance • ALIAXIN LV: Lips Volume

## Key facts

- **NCT ID:** NCT05808205
- **Lead sponsor:** Rose Pharma SA
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-06-30
- **Primary completion:** 2025-06-30
- **Final completion:** 2025-06-30
- **Target enrollment:** 350 (ESTIMATED)
- **Last updated:** 2024-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05808205

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05808205, "An Open, Non-comparative, Single-centre Post Marketing Clinical Followup (PMCF) Investigation to Evaluate Performance and Safety of the ALIAXIN Fillers Used as Intended". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05808205. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*